DrugPatentWatch Database Preview
Twi Pharms Company Profile
What is the competitive landscape for TWI PHARMS, and what generic and branded alternatives to TWI PHARMS drugs are available?
TWI PHARMS has ten approved drugs.
Summary for Twi Pharms
| US Patents: | 0 |
| Tradenames: | 10 |
| Ingredients: | 10 |
| NDAs: | 10 |
Drugs and US Patents for Twi Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Twi Pharms | GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201408-004 | Jun 2, 2015 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Twi Pharms | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 205231-004 | Aug 30, 2018 | AB3 | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Twi Pharms | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 205231-001 | Aug 30, 2018 | AB3 | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
